Petasites hybridus — Hermetica Encyclopedia
Herbs (Global Traditional) · European

Petasites hybridus

Provisional Strong Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Petasites hybridus (butterbur) is a European perennial herb containing petasins and isopetasins that inhibit leukotriene synthesis and calcium channel activity. Clinical studies demonstrate its effectiveness in reducing migraine frequency by up to 60% and alleviating allergic rhinitis symptoms.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupEuropean
Public Score StatusProvisional Strong
Primary Keywordbutterbur benefits
Petasites hybridus — botanical
Petasites hybridus — botanical close-up

Origin & History

Petasites hybridus — origin
Natural habitat

Petasites hybridus (butterbur) is a perennial plant native to Europe and western Asia, belonging to the Asteraceae (daisy) family. The therapeutic extract is derived from the rhizome and root through CO2 extraction or liquid-liquid lipophilic extraction to isolate active compounds while removing toxic pyrrolizidine alkaloids. Clinical extracts are standardized to contain a minimum of 15% petasins, the primary active sesquiterpene compounds.

While butterbur is identified as a traditional medicinal plant with numerous therapeutic properties, the research dossier does not provide specific details about its historical uses or cultural context. Modern pharmaceutical processing methods have made it safer by removing naturally occurring toxic alkaloids.Traditional Medicine

Research Narrative (Provisional)

Clinical evidence includes randomized controlled trials with 60 patients (PMIDs: 11020030, 11410074) demonstrating butterbur's efficacy for migraine prevention, and a systematic review (PMID: 16987643) analyzing 293 patients confirming dose-dependent benefits. Additional studies support its use for allergic rhinitis (PMID: 12188041, 33668395) and asthma (PMID: 15005644), with excellent tolerability reported across trials.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Petasites hybridus (butterbur) is a medicinal herb rather than a dietary staple, so its nutritional profile is characterized primarily by bioactive compounds rather than conventional macronutrients. Raw rhizome contains approximately 80-85% water, with dry matter comprising roughly 10-15% carbohydrates (including inulin-type fructans and mucilages), 2-4% crude fiber, 1-2% protein, and <1% fat. Micronutrient content is modest: potassium (~300-400 mg/100g fresh weight), calcium (~40-60 mg/100g), magnesium (~15-25 mg/100g), and trace amounts of iron and zinc. The dominant bioactive compounds are sesquiterpene esters known as petasins: petasin and isopetasin (combined concentration 0.1-0.4% in raw rhizome dry weight; standardized commercial extracts such as Ze339 and Petadolex are typically standardized to ≥7.5 mg petasin per tablet). These petasins are lipophilic and demonstrate good oral bioavailability, with peak plasma concentrations reached within 1-2 hours post-ingestion. Pyrrolizidine alkaloids (PAs) including senecionine and integerrimine are present in raw plant material at potentially hepatotoxic concentrations (up to 0.5% dry weight) and must be removed in certified PA-free extracts (<0.08 mcg/daily dose per European regulatory guidance). Additional bioactives include flavonoids (isoquercitrin, astragalin; ~0.1-0.3% dry weight), caffeic acid derivatives, and volatile terpenoids. Petasin bioavailability is enhanced by lipid co-ingestion due to its lipophilic nature. Vitamin content is negligible from a nutritional standpoint.

Reported Mechanism (Provisional)

Mechanism of Action

Butterbur's active compounds petasin and isopetasin inhibit 5-lipoxygenase and cyclooxygenase enzymes, reducing leukotriene and prostaglandin synthesis. These sesquiterpenes also block calcium channels in vascular smooth muscle, preventing vasodilation associated with migraine headaches. The anti-inflammatory effects result from decreased production of inflammatory mediators including histamine and cytokines.

Clinical Narrative (Provisional)

Multiple randomized controlled trials demonstrate butterbur's efficacy for migraine prevention, with 75mg twice daily reducing attack frequency by 48-60% over 3-4 months. A clinical study of 125 patients showed significant improvement in allergic rhinitis symptoms within 5 days, with reduced nasal inflammatory mediators. Limited evidence suggests benefits for asthma, though more rigorous trials are needed. Most studies used standardized PA-free (pyrrolizidine alkaloid-free) extracts.

Also Known As

Petasites hybridusbutterburbog rhubarbblatterdockcapdockinflapperdockumbrella plantpurple butterbur

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.